Achieving SVR Reduces Risk of Cardiovascular Events in Patients with HCV

Results highlight the benefit of achieving sustained virological response with DAAs for decreasing patients’ risk of carotid atherosclerosis and peripheral artery disease, especially among those with severe fibrosis.

Related Keywords

Romania ,Anca Trifan ,World Health Organization ,World Journal ,Internal Medicine ,Lancet Gatroenterology ,Thcv ,Hepatitisc Virus ,Sustained Virological Response ,Svr ,Carotid Atherosclerosis ,Daa ,Direct Acting Antivirals ,Peripheral Artery Disease ,Cirrhosis ,